Alpine Immune Sciences (ALPN) Insider Trading & Ownership → This company has increased its dividend every year for 54 years (From DTI) (Ad) Free ALPN Stock Alerts $64.43 -0.03 (-0.05%) (As of 04/18/2024 ET) Add Compare Share Share Insider TradesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Alpine Immune Sciences (NASDAQ:ALPN) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage42.30%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)3Amount OfInsider Selling(Last 12 Months)$6.45 M Get ALPN Insider Trade Alerts Want to know when executives and insiders are buying or selling Alpine Immune Sciences stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address ALPN Insider Buying and Selling by Quarter Ad The Bull ReportHealthcare Takes A Big Step Forward With The Help Of AIThe average doctor can diagnose an illness correctly 50-90% of the time. But one innovative company's medical AI gets it right 92%+.Click here to see why this small company is trusted by the Mayo Clinic Alpine Immune Sciences Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails1/25/2024James Paul RickeyinsiderSell236$22.00$5,192.00 12/27/2023Mitchell GoldCEOSell29,573$20.04$592,642.92 12/27/2023Peter A ThompsonDirectorSell181,498$19.96$3,622,700.08 12/22/2023Mitchell GoldCEOSell37,825$20.43$772,764.75 12/19/2023Mitchell GoldCEOSell2,402$20.01$48,064.02 12/18/2023James Paul RickeyinsiderSell1,800$19.00$34,200.00 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 12/14/2023James Paul RickeyinsiderSell11,600$19.00$220,400.00 12/12/2023Mitchell GoldCEOSell41,063$17.32$711,211.16 12/8/2023Mitchell GoldCEOSell8,067$17.08$137,784.36 12/5/2023James Paul RickeyinsiderSell418$16.01$6,692.18 11/30/2023James Paul RickeyinsiderSell700$16.00$11,200.00 11/6/2023James Paul RickeyinsiderSell18,003$16.03$288,588.09 (Data available from 1/1/2013 forward) ALPN Insider Trading Activity - Frequently Asked Questions Who is on Alpine Immune Sciences's Insider Roster? The list of insiders at Alpine Immune Sciences includes Decheng Capital China Life Sci, James Paul Rickey, Life Sciences Viii L Frazier, Mitchell Gold, Orbimed Advisors Llc, Peter A Thompson, and Robert E Conway. Learn more on insiders at ALPN. What percentage of Alpine Immune Sciences stock is owned by insiders? 42.30% of Alpine Immune Sciences stock is owned by insiders. Learn more on ALPN's insider holdings. Which Alpine Immune Sciences insiders have been selling company stock? The following insiders have sold ALPN shares in the last 24 months: James Paul Rickey ($566,272.27), Mitchell Gold ($2,262,467.21), and Peter A Thompson ($3,622,700.08). How much insider selling is happening at Alpine Immune Sciences? Insiders have sold a total of 333,185 Alpine Immune Sciences shares in the last 24 months for a total of $6,451,439.56 sold. More Insider Trading Tools from MarketBeat Related Companies: Rhythm Pharmaceuticals Insider Transactions Merus Insider Transactions Corcept Therapeutics Insider Transactions Summit Therapeutics Insider Transactions TG Therapeutics Insider Transactions Keros Therapeutics Insider Transactions Rocket Pharmaceuticals Insider Transactions Dyne Therapeutics Insider Transactions Maravai LifeSciences Insider Transactions MoonLake Immunotherapeutics Insider Transactions Insider Tracking Tools: CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country: U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles: The 5 Stocks Most Sold By Insiders This Year3 Cheap Stocks Insiders are Buying: Investors Should Avoid 1The 5 Hottest CEO Stock Purchases So Far This Year3 Cheap Stocks that Insiders Bought in Q1Michael Burry Picked a Winner With GEN Restaurant Group This page (NASDAQ:ALPN) was last updated on 4/18/2024 by MarketBeat.com Staff From Our PartnersThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingBiden’s $374B Giveaway Into This SectorDTIThe “Perfect Storm” for GoldGold Safe ExchangeBiden replacement revealed?Paradigm PressHe Is Giving Away BitcoinCrypto Swap ProfitsYour Money is Not SafeAmerican AlternativeThe Next Nvidia?InvestorPlaceTop 5 AI Stocks to Buy for 2024Market Moving Trends Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Alpine Immune Sciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.